A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: principles (564), values (295)

Obinutuzumab_maintenance

Description
Chemotherapy Protocol Non-Hodgkin Lymphoma Obinutuzumab (Maintenance) Regimen • NHL – Obinutuzumab (Maintenance) Indication • Obinutuzumab in combination with bendamustine followed by obinutuzumab maintenance
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Obinutuzumab-maintenance.pdf

CHOP(21)-Cyclophosphamide-Doxorubicin-Prednisolone-Vincristine (21) Ver 1.2

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-PREDNISOLONE-VINCRISTINE (21) (CHOP 21) Regimen Lymphoma – CHOP(21)-Cyclophosphamide-Doxorubicin-Prednisolone-Vincristine (21) Indication Non
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/CHOP21-Cyclophosphamide-Doxorubicin-Prednisolone-Vincristine-21-Ver-1.2.pdf

MyelomaPAD-Bortezomib(SC)DexamethasoneDoxorubicinVer1

Description
Chemotherapy Protocol MULTIPLE MYELOMA PAD (SC)-BORTEZOMIB (SC)-DEXAMETHASONE-DOXORUBICIN Regimen Multiple Myeloma – PAD (SC)-Bortezomib (SC)-Dexamethasone-Doxorubicin Indication Second
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaPAD-BortezomibSCDexamethasoneDoxorubicinVer1.pdf

MyelomaPAD-Bortezomib(IV)DexamethasoneDoxorubicinVer1

Description
Chemotherapy Protocol MULTIPLE MYELOMA PAD (IV)-BORTEZOMIB (IV)-DEXAMETHASONE-DOXORUBICIN Regimen Multiple Myeloma – PAD (IV)-Bortezomib (IV)-Dexamethasone-Doxorubicin Indication Second
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaPAD-BortezomibIVDexamethasoneDoxorubicinVer1.pdf

MyelomaMPVBortezomib(SC)MelphalanPrednisolone(35day)Ver1

Description
Chemotherapy Protocol MULTIPLE MYELOMA MPV (SC)-BORTEZOMIB (SC)-MELPHALAN (PO)-PREDNISOLONE (35 day) Regimen Multiple Myeloma – MPV(SC)-Bortezomib (SC)-Melphalan
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaMPVBortezomibSCMelphalanPrednisolone35dayVer1.pdf

MyelomaMPVBortezomib(IV)MelphalanPrednisolone(35day)Ver1

Description
Chemotherapy Protocol MULTIPLE MYELOMA MPV (IV)-BORTEZOMIB (IV)-MELPHALAN (PO)-PREDNISOLONE (35 day) Regimen Multiple Myeloma – MPV(IV)-Bortezomib (IV)-Melphalan
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaMPVBortezomibIVMelphalanPrednisolone35dayVer1.pdf

Preceptorship-Pledge

Description
Preceptorship Pledge Preceptorship definition ‘A period of structured transition for the newly registered practitioner during which he or she wil
Url
/Media/UHS-website-2019/Docs/Health-professionals/Education/preceptorship-pledge.pdf

Pertuzumab/Trastuzumab SC

Description
Chemotherapy Protocol BREAST CANCER Regimen Pertuzumab / Trastuzumab SC • Breast Cancer – Trastuzumab / Pertuzumab SC Indication • Treatment of early breast cancer (EBC) in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/PertuzumabTrastuzumab-SC.pdf

Cytarabine_2000_FludarabineIdarubicin_FLA-Ida

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (2000)-FLUDARABINE-IDARUBICIN (FLA-IDA) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (2000
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine-2000-FludarabineIdarubicin-FLA-Ida.pdf

Cytarabine_1000_FludarabineIdarubicin_FLA-Ida

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (1000)-FLUDARABINE-IDARUBICIN (FLA-IDA) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (1000
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine-1000-FludarabineIdarubicin-FLA-Ida.pdf
191 to 200 of 427
Previous … 18 19 20 21 22 … Next